Predicine to Introduce PredicineCOMPLETE™, its Genome-Wide Liquid Biopsy Solution at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting Silicon Valley, Calif., Nov 10, 2022 – Predicine, a global molecular insights company, announces the introduction of PredicineCOMPLETE™, the organization’s most comprehensive next-generation liquid biopsy solution that provides genome-wide, genomic and epigenomic insights to capture...